Search research articles
Contact Us
Filters
Showing results (61-70 of 74) with videos related to
Page
of 8
Sort By:
Histology and Histopathology
|
July 1, 1997
Hyperactive androgen receptor in prostate cancer: what does it mean for new therapy concepts?
Z Culig, A Hobisch, A Hittmair, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
December 1, 1993
Characterization of two point mutations in the androgen receptor gene of patients with perineoscrotal hypospadia
F Kaspar, A C Cato, A Denninger, et al.
Journal of Cell Science
|
March 21, 2001
Alteration of the stability of Bag-1 protein in the control of olfactory neuronal apoptosis
T Sourisseau, C Desbois, L Debure, et al.
Steroids
|
April 1, 1996
Interaction of the Ubc9 human homologue with c-Jun and with the glucocorticoid receptor
M Göttlicher, S Heck, V Doucas, et al.
Nucleic Acids Research
|
June 11, 1987
Partial overlapping of binding sequences for steroid hormone receptors and DNaseI hypersensitive sites in the rabbit uteroglobin gene region
K Jantzen, H P Fritton, T Igo-Kemenes, et al.
Molecular and Cellular Biology
|
December 1, 1988
Estrogen and progesterone receptor-binding sites on the chicken vitellogenin II gene: synergism of steroid hormone action
A C Cato, E Heitlinger, H Ponta, et al.
Molecular Endocrinology (Baltimore, Md.)
|
December 1, 1993
Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone
Z Culig, A Hobisch, M V Cronauer, et al.
Molecular and Cellular Endocrinology
|
March 25, 1996
CAG-repeat expansion in androgen receptor in Kennedy's disease is not a loss of function mutation
F Neuschmid-Kaspar, A Gast, H Peterziel, et al.
Cancer Detection and Prevention
|
January 1, 1996
Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosterone
Z Culig, J Stober, A Gast, et al.
European Urology
|
May 15, 1999
Mechanism of androgen receptor activation and possible implications for chemoprevention trials
H Klocker, Z Culig, I E Eder, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 74) with videos related to
Sort By:
Page
of 8
Histology and Histopathology
|
July 1, 1997
Hyperactive androgen receptor in prostate cancer: what does it mean for new therapy concepts?
Z Culig, A Hobisch, A Hittmair, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
December 1, 1993
Characterization of two point mutations in the androgen receptor gene of patients with perineoscrotal hypospadia
F Kaspar, A C Cato, A Denninger, et al.
Journal of Cell Science
|
March 21, 2001
Alteration of the stability of Bag-1 protein in the control of olfactory neuronal apoptosis
T Sourisseau, C Desbois, L Debure, et al.
Steroids
|
April 1, 1996
Interaction of the Ubc9 human homologue with c-Jun and with the glucocorticoid receptor
M Göttlicher, S Heck, V Doucas, et al.
Nucleic Acids Research
|
June 11, 1987
Partial overlapping of binding sequences for steroid hormone receptors and DNaseI hypersensitive sites in the rabbit uteroglobin gene region
K Jantzen, H P Fritton, T Igo-Kemenes, et al.
Molecular and Cellular Biology
|
December 1, 1988
Estrogen and progesterone receptor-binding sites on the chicken vitellogenin II gene: synergism of steroid hormone action
A C Cato, E Heitlinger, H Ponta, et al.
Molecular Endocrinology (Baltimore, Md.)
|
December 1, 1993
Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone
Z Culig, A Hobisch, M V Cronauer, et al.
Molecular and Cellular Endocrinology
|
March 25, 1996
CAG-repeat expansion in androgen receptor in Kennedy's disease is not a loss of function mutation
F Neuschmid-Kaspar, A Gast, H Peterziel, et al.
Cancer Detection and Prevention
|
January 1, 1996
Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosterone
Z Culig, J Stober, A Gast, et al.
European Urology
|
May 15, 1999
Mechanism of androgen receptor activation and possible implications for chemoprevention trials
H Klocker, Z Culig, I E Eder, et al.
Page
of 8